A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Phase 1 / Phase 2 · 10 sites
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 10 sites
Phase 2 · 1 site
Phase 1 / Phase 2 · 1 site
Phase 1 / Phase 2 · 8 sites
Phase 1 / Phase 2 · 1 site
Potential match only. Final eligibility is determined by the study team.